Skip to content

A Nutritional Study on the Effect of SINPHAR Walnut Peptide Powder on Improving the Cognitive Behavior of Middle-School Students and the Aged People

A Nutritional Study on the Effect of SINPHAR Walnut Peptide Powder on Improving the Cognitive Behavior of Middle-School Students and the Aged People

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028160
Enrollment
Unknown
Registered
2019-12-14
Start date
2019-12-13
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive behaviors

Interventions

Middle-school Students Group:High Dosage Gruop:Product Intervention
Middle-school Students Group:Commercial Dosage:Product Intervention
Middle-school Students Group:Control Group:Product Intervention
Middle-school Students Group:Placebo Group:Product Intervention
the Aged People Group:High Dosage:Product Intervention
the Aged People Group:Commercial Dosage:Product Intervention
the Aged People Group:Control Group:Product Intervention
the Aged People Group:Placebo Group:Product Intervention

Sponsors

SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD.(HANGZHOU)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Middle school students aged 12-16 years or seniors >= 65 years; 2. Be not regular consumer of milk; 3. Agree not to take any nutritional medications, supplements, or other dairy products including yogurt during the study; 4. A parent or legal guardian (at least one of them) has signed the informed consent form, and is willing to participate in the study and comply with the study design; 5. Agree not to participate in other interventional nutrition studies for the duration of the study; 6. Fully understand the nature, purpose, benefits and possible risks and side effects of this study.

Exclusion criteria

Exclusion criteria: 1. Be allergic to dairy products; 2. Severe intolerance to milk and dairy products; 3. Not agree to sign the informed consent form; 4. Took or have been taking antibiotics during screening or in the past two weeks; 5. Have been on a diet, getting more exercise or taking medications to control weight or affect appetite in the last 3 months; 6. Participation in other similar studies on dairy or probiotic products in the last 3 months; 7. Currently taking medication for cardiovascular or metabolic diseases; 8. Have any of the following medical history or be diagnosed to have the following diseases: obvious gastrointestinal disorders, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases, which may affect the evaluation of the study results; 9. Suffer from any gastrointestinal disorders or gastrointestinal diseases, including but not limited to allergic bowel syndrome, enteritis, ulcerative colitis, celiac disease, irritable bowel syndrome; 10. Hospitalization history in the 3 months before screening; 11. Currently be frequently taking medication that may affect gastrointestinal function or the immune system in the judgment of researchers.

Design outcomes

Primary

MeasureTime frame
Memory;PSQI;Collection and analysis of Chinese Language, Maths and English examination results (only for Middle-school Students Group);

Secondary

MeasureTime frame
Height, Weight, BMI;

Countries

China

Contacts

Public ContactLi Zhang

Sprim (Shanghai) Consulting Co., Ltd.

charlie.zhang@sprimmedical.com+86 13901981272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026